Sign in

CIK 0001676725 · Large accelerated filer

IDEAYA Biosciences, Inc.

Sign in to watch
Ticker
IDYA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
474268251
Phone
650-443-6209
Business address
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Planned sale Chief Legal Officer sold 3,837 shares at an average $30.03 ($115,222)
  2. 4 Planned sale See Remarks sold 2,000 shares at $30.01 ($60,016)
  3. 4 Planned sale Chief Financial Officer sold 5,000 shares at $28.87 ($144,352)
  4. 4 Planned sale Chief Financial Officer sold 978 shares at $26.40 ($25,819)
  5. 4 Planned sale Chief Financial Officer sold 4,022 shares at an average $26.38 ($106,105)
  6. 4 Planned sale Chief Legal Officer sold 5,000 shares at $25.09 ($125,430)
  7. 4 Planned sale Chief Financial Officer sold 2,500 shares at $25.05 ($62,613)
  8. 4 Planned sale Chief Legal Officer sold 9,485 shares at $23.00 ($218,178)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Planned sale Chief Legal Officer sold 3,985 shares at an average $23.02 ($91,729)
  19. 4 Planned sale Chief Legal Officer sold 500 shares at $23.00 ($11,500)
  20. 4 Option exercise Chief Financial Officer acquired 8,000 shares (option exercise)

Page 4 of 10 · 197 filings